Form 8-K ALNYLAM PHARMACEUTICALS, For: Nov 09

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Form 8-K ALNYLAM PHARMACEUTICALS, For: Nov 09

Alnylam Pharma (ALNY), Medicines Co. (MDCO) Announce Positive Data from Ongoing ALN-PCSsc Phase 1

November 11, 2015 10:47 AM EST

Alnylam Pharma (NASDAQ: ALNY) and The Medicines Company (Nasdaq: MDCO) reported positive results from their ongoing Phase 1 clinical trial with ALN-PCSsc in a late-breaking oral presentation at the American Heart Association (AHA) Scientific Sessions 2015.

ALN-PCSsc is an investigational RNAi therapeutic... More

Alnylam Pharma (ALNY) Reports In-Line Q3 EPS

November 9, 2015 7:13 AM EST

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($0.91), in-line with the analyst estimate of ($0.91). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $7.55 million.

"The past quarter and recent period were marked by tremendous progress in our efforts to... More